Zephyr AI is a healthcare technology company that reshapes traditional approaches to drug discovery and precision medicine.
Zephyr AI has raised $111.0M in total funding. The most recent round was Series A. The last funding was announced in March 2024.
Zephyr AI's investors include BoxGroup, Liquid 2 Ventures, MedStar Health, AME Cloud Ventures, Eli Lilly & Company Foundation.
Zephyr AI is headquartered in Fairfax Station, United States.
Zephyr AI is a healthcare technology company that reshapes traditional approaches to drug discovery and precision medicine.
Zephyr AI is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Zephyr AI — Funding & Investors." VCBacked, March 13, 2024, https://www.vcbacked.co/company/zephyr-ai. Accessed July 20, 2026.
VCBacked. (2024). Zephyr AI — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/zephyr-ai
{{cite web |title=Zephyr AI — Funding & Investors |url=https://www.vcbacked.co/company/zephyr-ai |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated